Laboratory markers of thrombosis risk in children with hereditary spherocytosis

Pediatric Blood and Cancer

Volumn 49, Issue 6, 2007, Pages 781-785

  Troendle, Sarah B ^a   Adix, Leah ^b   Crary, Shelley E ^a   Buchanan, George R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

Children; Hereditary; Spherocytosis; Splenectomy; Thrombosis

Indexed keywords

CHOLESTEROL; HEMOGLOBIN;

ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; DISEASE MARKER; FOLLOW UP; HEREDITARY SPHEROCYTOSIS; HUMAN; HYPOCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; POLYCYTHEMIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SPLENECTOMY; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTOSIS; THROMBOSIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DATABASES, FACTUAL; HEMOGLOBINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PLATELET COUNT; POLYCYTHEMIA; RETROSPECTIVE STUDIES; RISK FACTORS; SPHEROCYTOSIS, HEREDITARY; SPLENECTOMY; THROMBOCYTOSIS; THROMBOSIS;

EID: 34948901313     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21319     Document Type: Article

References (39)

1. Schilling RF. Spherocytosis, splenectomy, strokes, and heart attacks. Lancet 1997;350:1677-1678.
2. Hoeper MM, Niedermeyer J, Hoffmeyer F, et al. Pulmonary Hypertension after Splenectomy? Ann Intern Med 1999;130:506-509.
3. Pimpl W, Dapunt O, Kaindl H, et al. Incidence of septic and thromboembolic-related deaths after splenectomy in adults. Br J Surg 1989;76:17-521.
4. Robinette CD, Fraumeni JF, Jr. Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet 1977;2:127-129.
5. Bertolotti M, Loria P, Martella P, et al. Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis. Dig Dis Sci 2000;45:373-377.
6. Jardine DL, Laing AD. Delayed pulmonary hypertension following splenectomy for congenital spherocytosis. Intern Med J 2004;34:214-216.
7. Hayag-Barin JE, Smith RE, Tucker FC, Jr. Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: A case report and review of the literature. Am J Hematol 1998;57:82-84.
8. McGrew W, Avant GR. Hereditary spherocytosis and portal vein thrombosis. J Clin Gastroenterol 1984;6:381-382.
9. Schilling RF, Gangnon RE, Traver M. Arteriosclerotic events are less frequent in persons with chronic anemia: Evidence from families with hereditary spherocytosis. Am J Hematol 2006;81:315-317.
10. Dallman PR, Siimes MA. Percentile curves for hemoglobin and red cell volume in infancy and childhood. J Pediatr 1979;94:26-31.
11. Hickman TB, Briefel RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: Data from the Third National Health and Nutrition Examination Survey. Prev Med 1998;27:879-890.
12. Asai K, Kuzuya M, Naito M, et al. Effects of splenectomy on serum lipids and experimental atherosclerosis. Angiology 1988;39:497-504.
13. Fatouros M, Bourantas K, Bairaktari E, et al. Role of the spleen in lipid metabolism. Br J Surg 1995;82:1675-1677.
14. Bolton-Maggs PH. Hereditary spherocytosis; new guidelines. Arch Dis Child 2004;89:809-812.
15. Visudhiphan S, Ketsa-Ard K, Piankijagum A, et al. Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis. The relationship to thromboembolism. Biomed Pharmacother 1985;39:264-271.
16. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: Role of nitric oxide and hemolytic anemia. Hematology (Am Soc Hematol Educ Program) 2005; 51-57.
17. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002;99:36-43.
18. Cynober T, Mohandas N, Tchernia G. Red cell abnormalities in hereditary spherocytosis: Relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med 1996;128:259-269.
19. Mackinney AA, Jr, Morton NE, Kosower NS, et al. Ascertaining genetic carriers of hereditary spherocytosis by statistical analysis of multiple laboratory tests. J Clin Invest 1962;41:554-567.
20. Reinhart WH, Wyss EJ, Arnold D, et al. Hereditary spherocytosis associated with protein band 3 defect in a Swiss kindred. Br J Haematol 1994;86:147-155.
21. Schilling RF. Hereditary spherocytosis: A study of splenectomized persons. Semin Hematol 1976;13:169-176.
22. Kannel WB, Gordon T, Wolf PA, et al. Hemoglobin and the risk of cerebral infarction: The Framingham study. Stroke 1972;3:409-420.
23. Robertson DA, Simpson FG, Losowsky MS. Blood viscosity after splenectomy. Br Med J (Clin Res Ed) 1981;283:573-575.
24. Djousse L, Levy D, Cupples LA, et al. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001;87:1196-1200.
25. Djousse L, Rothman KJ, Cupples LA, et al. Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham offspring study). Am J Cardiol 2003;91:485-488.
26. Hopkins PN, Wu LL, Hunt SC, et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996;16:250-255.
27. Ishizaka N, Ishizaka Y, Takahashi E, et al. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke 2001;32:580-583.
28. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: A meta-analysis of published studies. Exp Biol Med (Maywood) 2003;228:568-571.
29. Vitek L, Novotny L, Sperl M, et al. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis 2006;21:408-414.
30. Sedlak TW, Snyder SH. Messenger molecules and cell death: Therapeutic implications. JAMA 2006;295:81-89.
31. Hirsh J, Dacie JV. Persistent post-splenectomy thrombocytosis and thrombo-embolism: A consequence of continuing anaemia. Br J Haematol 1966;12:44-53.
32. Goodman J, Newman MI. Disorders of the Spleen. New York: Lippincott, Williams & Wilkins; 2004. 1905-1906 p.
33. Aviram M, Brook JG, Tatarsky I, et al. Increased low-density lipoprotein levels after splenectomy: A role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am J Med Sci 1986;291:25-28.
34. Johnsson R, Saris NE. Plasma and erythrocyte lipids in hereditary spherocytosis. Clin Chim Acta 1981;114:263-268.
35. Rifkind BM, Gale M. Hypolipidaemia in anaemia. Implications for the epidemiology of ischaemic heart-disease. Lancet 1967;2:640-642.
36. Sugihara T, Yawata Y. Observations on plasma and red cell lipids in hereditary spherocytosis. Clin Chim Acta 1984;137:227-232.
37. Westerman MP. Hypocholesterolaemia and anaemia. Br J Haematol 1975;31:87-94.
38. Cohen JC, Boerwinkle E, Mosley TH, Jr, et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354:1264-1272.
39. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III). JAMA 2001;285:2486-2497.